← Leaderboards
Eric G. Meissner
Medical University Of South Carolina
$1,817,398
Attributed
$1,817,398
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $343.7K · FY2016–23$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,817,398 · 2
By mechanism
P20$944,409 · 1
K08$872,989 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Andrew David Schreiner$3,774,805
- Beichu Guo$270,000
Others in their field
Top investigators on “Chronic Hepatitis C”
- Charles M. Rice · Rockefeller University$34,363,917
- Gregory D Kirk · Johns Hopkins University$28,294,149
- Richard Douglas Moore · Johns Hopkins University$26,794,566
- David L Thomas · Johns Hopkins University$26,415,115
- Christopher M. Walker · Research Inst Nationwide Children'S Hosp$22,237,021
- Raymond T Chung · Massachusetts General Hospital$19,709,082
Research focus
Chronic Hepatitis CTreatment OutcomeViral ProteinsVirus DiseasesResponsePathway InteractionsHepatocyteSignal TransductionImmunitySamplingLigandsInterferonsLiverNatural ImmunityAntiviral AgentsHepatitis CAdaptive ImmunityInsightAffectImmune ResponseInflammationChronicBaseHepatitis C Therapy
Grant awards (9)
Project 2: Dissection of Type-III Interferon Signaling in iPSC-Derived Hepatocytes$171,110
P20 · FY2023 · GM · contact PI
Project 2: Dissection of Type-III Interferon Signaling in iPSC-Derived Hepatocytes$255,813
P20 · FY2022 · GM · contact PI
Project 2: Dissection of Type-III Interferon Signaling in iPSC-Derived Hepatocytes$264,202
P20 · FY2021 · GM · contact PI
Project 2: Dissection of Type-III Interferon Signaling in iPSC-Derived Hepatocytes$253,284
P20 · FY2020 · GM · contact PI
Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy$90,410
K08 · FY2020 · AI · contact PI
Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy$199,314
K08 · FY2019 · AI · contact PI
Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy$199,314
K08 · FY2018 · AI · contact PI
Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy$199,314
K08 · FY2017 · AI · contact PI
Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy$184,637
K08 · FY2016 · AI · contact PI